Taste Evaluation of Different Liquid Formulations With Eliglustat

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Primary Objective:

The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Genzyme, a Sanofi Company
• Treatments: Eliglustat

Criteria

Inclusion criteria :

• Healthy male and female subjects, 18 to 55 years of age, inclusive.

• Normal smell and taste ability to discriminate odor and flavor differences.

Exclusion criteria:

• Poor metabolizer phenotype status for CYP2D6 (predicted based on genotype).

• Subject who has smoked within 3 months of inclusion.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.